Financial results - NEUROLIFE SRL

Financial Summary - Neurolife Srl
Unique identification code: 21598170
Registration number: J16/803/2007
Nace: 8622
Sales - Ron
160.411
Net Profit - Ron
110.067
Employee
3
The most important financial indicators for the company Neurolife Srl - Unique Identification Number 21598170: sales in 2023 was 160.411 euro, registering a net profit of 110.067 euro and having an average number of 3 employees. Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Neurolife Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 64.018 62.183 54.212 61.711 79.218 84.705 102.817 126.981 135.398 160.411
Total Income - EUR 64.633 62.868 57.407 62.564 79.233 84.705 102.818 126.981 135.399 162.433
Total Expenses - EUR 32.587 34.595 29.669 27.372 29.568 43.868 36.728 31.613 36.365 50.742
Gross Profit/Loss - EUR 32.046 28.273 27.738 35.192 49.666 40.837 66.089 95.368 99.034 111.692
Net Profit/Loss - EUR 30.107 26.387 27.164 34.567 48.873 39.990 65.131 94.098 97.680 110.067
Employees 6 3 3 3 3 3 3 3 3 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 18.8%, from 135.398 euro in the year 2022, to 160.411 euro in 2023. The Net Profit increased by 12.683 euro, from 97.680 euro in 2022, to 110.067 in the last year.

Check the financial reports for the company - Neurolife Srl

Rating financiar

Financial Rating -
Neurolife Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Neurolife Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Neurolife Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Neurolife Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Neurolife Srl - CUI 21598170

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 16.091 12.625 7.247 3.951 3.317 6.360 4.722 15.968 13.608 33.887
Current Assets 138.538 169.851 80.111 31.689 80.722 38.587 61.987 79.800 85.962 80.509
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 507 1 5.081 3.296 5.205 8.366 5.314 8.372 50.130 62.797
Cash 138.030 169.850 75.030 28.393 75.517 30.221 56.674 71.428 35.832 17.712
Shareholders Funds 153.359 181.382 84.222 34.619 82.857 40.040 65.180 94.147 97.729 110.116
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 1.269 1.094 3.136 1.020 1.181 8.503 1.529 1.621 1.841 4.280
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 80.509 euro in 2023 which includes Inventories of 0 euro, Receivables of 62.797 euro and cash availability of 17.712 euro.
The company's Equity was valued at 110.116 euro, while total Liabilities amounted to 4.280 euro. Equity increased by 12.683 euro, from 97.729 euro in 2022, to 110.116 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Neurolife Srl

Comments - Neurolife Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.